| Literature DB >> 35582956 |
Eduardo C Costa1,2, Rodrigo A V Browne2, Marcyo Câmara2, Geovani A D Macêdo1, Bruno E B Lucena2, Lauro C Vianna3, Todd A Duhamel4,5.
Abstract
Although it has been suggested that increased arterial stiffness is linked to exaggerated blood pressure (BP) from brief moderate exercise, it is not clear whether this occurs in older adults with and without hypertension. This study investigates whether the immediate post-exercise systolic BP following brief moderate exercise is associated with arterial stiffness in older females with different BP status. This cross-sectional study included 191 older females aged 60-80 years without known cardiovascular disease (CVD). Arterial stiffness was determined by aortic pulse wave velocity (aPWV). Systolic BP was measured before and immediately following a 3-min moderate walking test (stage 1 Bruce protocol). Specific quartile-based thresholds were used to define an exaggerated immediate post-exercise systolic BP for hypertensive and normotensive older females (quartile 4 as an exaggerated response). Traditional CVD risk factors were assessed (covariates). Older females from the highest quartile of immediate post-exercise absolute systolic BP showed higher aPWV compared to their peers from the lowest quartile (β = .22 m/s, p = .018). The quartile-based threshold to define the exaggerated post-exercise systolic BP was higher in hypertensive than in normotensive older females (174 vs. 172 mmHg). In summary, exaggerated immediate post-exercise systolic BP following a brief moderate exercise is associated with higher arterial stiffness in older females with different BP status.Entities:
Keywords: aging; arterial compliance; exaggerated exercise blood pressure; exercise-induced hypertension; pulse wave velocity; vascular health
Mesh:
Year: 2022 PMID: 35582956 PMCID: PMC9180321 DOI: 10.1111/jch.14490
Source DB: PubMed Journal: J Clin Hypertens (Greenwich) ISSN: 1524-6175 Impact factor: 2.885
FIGURE 1Study flowchart. BP, blood pressure
Characteristics of the older females (n = 191)
| Mean ± SD or | |
|---|---|
| Age, years | 65.8 ± 5.3 |
|
Living with partner, | 110 (57.6) |
|
Post‐secondary education, | 35 (18.3) |
|
| 119 (62.3) |
|
White, | 72 (37.7) |
|
Ex‐smokers/smokers, | 73 (38.2) |
|
Pre‐frail/frail, | 118 (61.8) |
| Six‐minute walk test, m | 484 ± 67 |
| Body fat, % | 43.6 ± 5.1 |
| Body mass index, kg/m2 | 28.9 ± 4.6 |
| Fasting glucose, mg/dl | 109.4 ± 29.3 |
| Triglycerides, mg/dl | 150.9 ± 76.7 |
| HDL‐cholesterol, mg/dl | 47.9 ± 12.6 |
| LDL‐cholesterol, mg/dl | 133.2 ± 44.0 |
| Total cholesterol, mg/dl | 207.9 ± 45.2 |
|
Diabetes medication, | 47 (24.6) |
|
Lipid‐lowering medication, | 62 (32.5) |
|
Antihypertensive medication, | 109 (57.1) |
| Monotherapy | 48 (44.0) |
| Combination therapy | 61 (56.0) |
| Calcium channel blockers | 10 (9.2) |
| Diuretics | 47 (43.1) |
| Angiotensin II receptor blockers | 85 (78.0) |
| ACE inhibitors | 9 (8.3) |
| Beta‐blockers | 31 (28.4) |
| Resting SBP, mmHg | 125.1 ± 14.2 |
| Resting DBP, mmHg | 70.1 ± 8.5 |
| Resting PP, mmHg | 55.0 ± 10.6 |
| Immediate post‐exercise SBP, mmHg | 159.2 ± 22.2 |
| Change in immediate post‐exercise SBP, mmHg | 34.3 ± 17.7 |
| Aortic pulse wave velocity, m/s | 9.4 ± 1.0 |
| Framingham risk score, n (%) | |
| Low risk (< 10%) | 63 (33.0) |
| Moderate risk (≥10% and <20%) | 93 (48.7) |
| High risk (≥20%) | 35 (18.3) |
Note: Data are shown as mean ± SD or absolute (n) and relative (%) frequencies.
Abbreviations: ACE, angiotensin‐converting‐enzyme; BP, blood pressure; DBP, diastolic blood pressure; HDL, high‐density lipoprotein; LDL, low‐density lipoprotein; PP, pulse pressure; SBP, systolic blood pressure.
FIGURE 2Coefficient estimates (β) and its 95% Wald confidence interval (CI) for aortic pulse wave velocity (aPWV) according to quartiles of immediate post‐exercise absolute systolic blood pressure (panel A) and to quartiles of absolute change in immediate post‐exercise systolic blood pressure (panel B) of older females (n = 191). Analysis adjusted for age, race, smoking status, resting systolic blood pressure, body fat percentage, HDL‐cholesterol, total cholesterol, diabetes medication, antihypertensive medication, and Fried frailty phenotype. Goodness of fit of the model: p < 0.001 in the Omnibus test
Coefficient estimates for pulse wave velocity according to quartiles of immediate post‐exercise absolute systolic blood pressure of older females (n = 191)
| aPWV, m/s | |||
|---|---|---|---|
|
β | 95% Wald CI |
| |
| Post‐exercise SBP (per‐mmHg increase) | |||
| 1 mmHg | .00 | .00, .01 | .089 |
| 5 mmHg | .01 | .00, .03 | .089 |
| 10 mmHg | .03 | .00, .06 | .089 |
| 15 mmHg | .04 | ‐.01, .09 | .089 |
| 20 mmHg | .05 | ‐.01, .11 | .089 |
| Post‐exercise SBP (per quartile) | |||
| Q1 HT ≤ 146 mmHg; NT ≤ 142 mmHg | Ref. | ||
| Q2 HT 147–162 mmHg; NT 143–153 mmHg | .03 | –.12, .18 | .711 |
| Q3 HT 163–173 mmHg; NT 154–171 mmHg | .10 | –.06, .25 | .242 |
| Q4 HT ≥ 174 mmHg; NT ≥ 172 | .22 | .04, .40 |
|
Note: Data are shown as coefficient estimates (β), and 95% Wald confidence interval (CI).
Bold values indicate significance at p < .05.
Abbreviations: aPWV, aortic pulse wave velocity; Q, quartile; SBP, systolic blood pressure.
Analysis adjusted for age, race, smoking status, resting systolic blood pressure, body fat percentage, HDL‐cholesterol, total cholesterol, diabetes medication, antihypertensive medication, and Fried frailty phenotype. Goodness of fit of the model: p < .001 in Omnibus test.
Coefficient estimates for pulse wave velocity according to quartiles of absolute change in immediate post‐exercise systolic blood pressure of older females (n = 191)
| aPWV, m/s | |||
|---|---|---|---|
|
β | 95% Wald CI |
| |
| Δ post‐exercise SBP (per‐mmHg increase) | |||
| 1 mmHg | .00 | .00, .01 | .077 |
| 5 mmHg | .01 | .00, .03 | .077 |
| 10 mmHg | .03 | .00, .06 | .077 |
| 15 mmHg | .04 | .00, .09 | .077 |
| 20 mmHg | .06 | ‐.01, .12 | .077 |
| Δ post‐exercise SBP (per quartile) | |||
| Q1 HT ≤ 24 mmHg; NT ≤ 23 mmHg | .00 | Reference | |
| Q2 HT 25–34 mmHg; NT 24–31 mmHg | .05 | –.10, .20 | .512 |
| Q3 HT 35–47 mmHg; NT 32–42 mmHg | .16 | .01, .31 |
|
| Q4 HT ≥ 48 mmHg; NT ≥ 43 mmHg | .16 | .01, .31 |
|
Note: Data are shown as coefficient estimates (β), and 95% Wald confidence interval (CI).
Bold values indicate significance at p < .05.
Abbreviations: aPWV, aortic pulse wave velocity; HY, hypertensive; NT, normotensive; Q, quartile.; SBP, systolic blood pressure.
Analysis adjusted for age, race, smoking status, resting systolic blood pressure, body fat percentage, HDL‐cholesterol, total cholesterol, diabetes medication, antihypertensive medication, and Fried frailty phenotype. Goodness of fit of the model: p < .001 in Omnibus test.
Characteristics of the older females according to quartiles of immediate post‐exercise absolute systolic blood pressure (n = 191)
| Quartile 1 | Quartile 2 | Quartile 3 | Quartile 4 |
| |
|---|---|---|---|---|---|
|
| 48 (25.1) | 50 (26.2) | 48 (25.1) | 45 (23.6) | |
| Age, years | 65.5 ± 5.1 | 66.1 ± 4.8 | 65.6 ± 6.3 | 65.8 ± 4.8 | .951 |
|
Living with partner, | 25 (52.1) | 33 (66.0) | 26 (54.2) | 26 (57.8) | .519 |
|
Post‐secondary education, | 33 (68.8) | 42 (84.0) | 38 (79.2) |
43 (95.6) |
|
|
| 27 (56.3) | 32 (64.0) | 28 (58.3) | 32 (71.1) | .454 |
|
White, | 21 (43.8) | 18 (36.0) | 20 (41.7) | 13 (28.9) | |
|
Ex‐smokers/smokers, | 20 (41.7) | 17 (34.0) | 19 (39.6) | 17 (37.8) | .886 |
|
Pre‐frail/Frail, | 29 (60.4) | 29 (58.0) | 32 (66.7) | 28 (62.2) | .845 |
| Six‐minute walk test, m | 485 ± 69 | 483 ± 63 | 485 ± 74 | 483 ± 62 | .997 |
| Body fat, % | 43.6 ± 5.1 | 43.8 ± 4.5 | 42.8 ± 6.1 | 44.4 ± 4.5 | .505 |
| Body mass index, kg/m2 | 28.6 ± 5.2 | 29.5 ± 4.5 | 28.4 ± 5.2 | 29.0 ± 3.5 | .678 |
| Fasting glucose, mg/dl | 108.0 ± 27.6 | 107.9 ± 23.7 | 107.3 ± 33.7 | 115.0 ± 31.7 | .533 |
| Triglycerides, mg/dl | 140.8 ± 56.7 | 158.7 ± 76.1 | 147.3 ± 68.1 | 156.6 ± 101.8 | .525 |
| HDL‐cholesterol, mg/dl | 46.9 ± 10.5 | 47.1 ± 14.5 | 49.0 ± 13.7 | 48.8 ± 11.1 | .762 |
| LDL‐cholesterol, mg/dl | 131.8 ± 45.6 | 125.2 ± 44.6 | 137.6 ± 37.4 | 139.1 ± 48.0 | .365 |
| Total cholesterol, mg/dl | 204.0 ± 46.1 | 200.6 ± 45.6 | 212.6 ± 38.6 | 215.3 ± 50.0 | .315 |
|
Diabetes medication, | 11 (22.9) | 11 (22.0) | 13 (27.1) | 12 (26.7) | .930 |
|
Lipid‐lowering medication, | 11 (22.9) | 20 (40.0) | 17 (35.4) | 14 (31.1) | .322 |
|
Antihypertensive medication, | 27 (56.3) | 29 (58.0) | 28 (58.3) | 25 (55.6) | .991 |
| Resting SBP, mmHg | 114 ± 12 |
123 ± 11 |
128 ± 12 |
136 ± 12 |
|
| Resting DBP, mmHg | 65 ± 7 |
70 ± 7 |
71 ± 8 |
75 ± 9 |
|
| Resting PP, mmHg | 49 ± 10 | 53 ± 10 |
57 ± 10 |
61 ± 9 |
|
| Immediate post‐exercise SBP, mmHg | 132 ± 12 |
153 ± 6 |
165 ± 5 |
189 ± 12 |
|
| Change in immediate post‐exercise SBP, mmHg | 18 ± 13 |
30 ± 12 |
38 ± 11 |
53 ± 15 |
|
| Pulse wave velocity, m/s | 9.1 ± 1.1 | 9.4 ± .9 | 9.5 ± 1.2 |
9.8 ± .9 |
|
|
Framingham risk score, | |||||
| Low risk (<10%) | 21 (43.8) | 16 (32.0) | 17 (35.4) | 9 (20.0) | .080 |
| Moderate risk (≥10% and <20%) | 24 (50.0) | 25 (50.0) | 19 (39.6) | 25 (55.6) | |
| High risk (≥20%) | 3 (6.3) | 9 (18.0) | 12 (25.0) | 11 (24.4) |
Note: Data are shown as mean ± SD or absolute (n) and relative (%) frequencies.
Bold values indicate significance at p < .05.
Abbreviations: BP, blood pressure; DBP, diastolic blood pressure; HDL, high‐density lipoprotein; LDL, low‐density lipoprotein; PP, pulse pressure; Quartile 2: immediate post‐exercise absolute systolic BP 147–162 mmHg for hypertensive and 143–153 mmHg for normotensive; Quartile 3 immediate post‐exercise absolute systolic BP 163–173 mmHg for hypertensive and 154–171 mmHg for normotensive; Quartile 4: immediate post‐exercise absolute systolic BP ≥ 174 mmHg for hypertensive and ≥172 mmHg for normotensive.; SBP, systolic blood pressure. Quartile 1: immediate post‐exercise absolute systolic BP ≤ 146 mmHg for hypertensive and ≤ 142 mmHg for normotensive.
Different from quartile 1 (p < .05).
Different from quartile 2 (p < .05).
Different from quartile 3 (p < .05).
Characteristics of the older females according to quartiles of absolute change in immediate post‐exercise systolic blood pressure (n = 191)
| Quartile 1 | Quartile 2 | Quartile 3 | Quartile 4 |
| |
|---|---|---|---|---|---|
|
| 53 (27.7) | 45 (23.6) | 47 (24.6) | 46 (24.1) | |
| Age, years | 66.3 ± 5.8 | 65.0 ± 5.2 | 64.6 ± 5.2 | 67.1 ± 4.5 | .071 |
|
Living with partner, | 28 (52.8) | 28 (62.2) | 24 (51.1) | 30 (65.2) | .424 |
|
Post‐secondary education, | 10 (18.9) | 11 (24.4) | 12 (25.5) |
2 (4.3) |
|
|
| 32 (60.4) | 25 (55.6) | 29 (61.7) | 33 (71.7) | .444 |
|
White, | 21 (39.6) | 20 (44.4) | 18 (38.3) | 13 (28.3) | |
|
Ex‐smokers/smokers, | 20 (37.7) | 16 (35.6) | 19 (40.4) | 18 (39.1) | .969 |
|
Pre‐frail/Frail, | 33 (62.3) | 28 (62.2) | 29 (61.7) | 28 (60.9) | 1.000 |
| Six‐minute walk test, m | 485 ± 65 | 488 ± 69 | 491 ± 70 | 470 ± 64 | .423 |
| Body fat, % | 43.1 ± 4.5 | 43.2 ± 5.3 | 43.3 ± 6.3 | 45.0 ± 3.9 | .248 |
| Body mass index, kg/m2 | 28.6 ± 5.1 | 28.5 ± 4.2 | 28.7 ± 5.0 | 29.7 ± 4.1 | .554 |
| Fasting glucose, mg/dl | 107.9 ± 26.4 | 110.0 ± 25.7 | 106.9 ± 33.2 | 113.2 ± 31.9 | .617 |
| Triglycerides, mg/dl | 155.1 ± 78.0 | 145.8 ± 53.9 | 139.0 ± 75.0 | 163.0 ± 94.4 | .341 |
| HDL‐cholesterol, mg/dl | 46.8 ± 11.5 | 47.2 ± 14.4 | 50.1 ± 13.9 | 47.7 ± 10.3 | .579 |
| LDL‐cholesterol, mg/dl | 126.6 ± 38.7 | 138.6 ± 50.4 | 133.4 ± 43.1 | 135.5 ± 44.4 | .547 |
| Total cholesterol, mg/dl | 199.8 ± 38.7 | 211.8 ± 50.9 | 208.6 ± 44.9 | 212.8 ± 46.9 | .451 |
|
Diabetes medication, | 12 (22.6) | 12 (26.7) | 9 (19.1) | 14 (30.4) | .612 |
|
Lipid‐lowering medication, | 13 (24.5) | 18 (40.0) | 15 (31.9) | 16 (34.8) | .431 |
|
Antihypertensive medication, | 30 (56.6) | 25 (55.6) | 27 (57.4) | 27 (58.7) | .994 |
| Resting SBP, mmHg | 127 ± 15 | 125 ± 15 | 123 ± 13 | 124 ± 14 | .611 |
| Resting DBP, mmHg | 70 ± 8 | 71 ± 8 | 69 ± 8 | 70 ± 9 | .635 |
| Resting PP, mmHg | 57 ± 12 | 54 ± 11 | 55 ± 10 | 54 ± 10 | .485 |
| Immediate post‐exercise SBP, mmHg | 141 ± 18 |
153 ± 15 |
162 ± 14 |
182 ± 18 |
|
| Change in immediate post‐exercise SBP, mmHg | 14 ± 9 |
28 ± 3 |
39 ± 4 |
58 ± 9 |
|
| Aortic pulse wave velocity, m/s | 9.5 ± 1.2 | 9.3 ± 1.0 | 9.3 ± 1.0 | 9.7 ± .9 | .107 |
|
Framingham risk score, | |||||
| Low risk (<10%) | 16 (30.2) | 18 (40.0) | 15 (31.9) | 14 (30.4) | .756 |
| Moderate risk (≥10% and <20%) | 27 (50.9) | 19 (42.2) | 21 (44.7) | 26 (56.5) | |
| High risk (≥20%) | 10 (18.9) | 8 (17.8) | 11 (23.4) | 6 (13.0) |
Note: Data are shown as mean ± SD or absolute (n) and relative (%) frequencies.
Bold values indicate significance at p < .05.
Abbreviations: BP, blood pressure; DBP, diastolic blood pressure; HDL, high‐density lipoprotein; LDL, low‐density lipoprotein; PP, pulse pressure; Quartile 2: absolute change in immediate post‐exercise systolic BP 25–34 mmHg for hypertensive and 24–31 mmHg for normotensive; Quartile 3 absolute change in immediate post‐exercise systolic BP 35–47 mmHg for hypertensive and 32–42 mmHg for normotensive; Quartile 4: absolute change in immediate post‐exercise systolic BP ≥ 48 mmHg for hypertensive and ≥ 43 mmHg for normotensive.; SBP, systolic blood pressure. Quartile 1: absolute change in immediate post‐exercise systolic BP ≤ 24 mmHg for hypertensive and ≤ 23 for normotensive.
Different from quartile 1 (p < .05).
Different from quartile 2 (p < .05).
Different from quartile 3 (p < .05).